951884-02-9 Usage
Uses
Used in Synthetic Chemistry:
Methyl 5-bromo-4-chloro-2-fluorobenzoate is used as a synthetic intermediate for the production of various chemical compounds. Its unique structure with multiple halogens allows for versatile synthetic transformations, making it a valuable building block in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Methyl 5-bromo-4-chloro-2-fluorobenzoate is used as a key intermediate in the synthesis of drug molecules. Its presence in the molecular structure can impart specific biological activities or improve the pharmacokinetic properties of the final drug product, such as solubility, stability, or bioavailability.
Used in Agrochemical Industry:
Methyl 5-bromo-4-chloro-2-fluorobenzoate is also used in the agrochemical industry as a precursor for the synthesis of pesticides and other crop protection agents. The introduction of halogens in the molecule can enhance the pesticidal activity or selectivity, leading to more effective and environmentally friendly products.
Used in Specialty Chemicals:
Methyl 5-bromo-4-chloro-2-fluorobenzoate is employed in the production of specialty chemicals, such as dyes, pigments, and polymer additives. The presence of halogens in the molecule can influence the color, stability, or other properties of these materials, making them suitable for specific applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 951884-02-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,1,8,8 and 4 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 951884-02:
(8*9)+(7*5)+(6*1)+(5*8)+(4*8)+(3*4)+(2*0)+(1*2)=199
199 % 10 = 9
So 951884-02-9 is a valid CAS Registry Number.
951884-02-9Relevant articles and documents
GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO
-
, (2008/12/04)
GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure, wherein R1a, R1b, R1c, R1d, R2, R2a, and A are as defined herein, including stereoisomers, esters, solvates and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.
